Finally, Nrg4 transgenic mice significantly improved lipid metabolism disorders and hepatic steatosis, supporting the potential therapeutic role of Nrg4 in NAFLD (Wang et al., 2014). The gene discussed is NRG4; the disease is fatty liver disease.